IBDEI2SO ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,44559,1,4,0)
;;=4^T38.3X6A
;;^UTILITY(U,$J,358.3,44559,2)
;;=^5049649
;;^UTILITY(U,$J,358.3,44560,0)
;;=T38.3X6S^^164^2208^4
;;^UTILITY(U,$J,358.3,44560,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44560,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
;;^UTILITY(U,$J,358.3,44560,1,4,0)
;;=4^T38.3X6S
;;^UTILITY(U,$J,358.3,44560,2)
;;=^5049651
;;^UTILITY(U,$J,358.3,44561,0)
;;=T38.3X6D^^164^2208^5
;;^UTILITY(U,$J,358.3,44561,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44561,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
;;^UTILITY(U,$J,358.3,44561,1,4,0)
;;=4^T38.3X6D
;;^UTILITY(U,$J,358.3,44561,2)
;;=^5049650
;;^UTILITY(U,$J,358.3,44562,0)
;;=T46.5X6A^^164^2208^9
;;^UTILITY(U,$J,358.3,44562,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44562,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
;;^UTILITY(U,$J,358.3,44562,1,4,0)
;;=4^T46.5X6A
;;^UTILITY(U,$J,358.3,44562,2)
;;=^5051353
;;^UTILITY(U,$J,358.3,44563,0)
;;=T46.5X6D^^164^2208^10
;;^UTILITY(U,$J,358.3,44563,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44563,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
;;^UTILITY(U,$J,358.3,44563,1,4,0)
;;=4^T46.5X6D
;;^UTILITY(U,$J,358.3,44563,2)
;;=^5051354
;;^UTILITY(U,$J,358.3,44564,0)
;;=T46.5X6S^^164^2208^11
;;^UTILITY(U,$J,358.3,44564,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44564,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Sequela
;;^UTILITY(U,$J,358.3,44564,1,4,0)
;;=4^T46.5X6S
;;^UTILITY(U,$J,358.3,44564,2)
;;=^5051355
;;^UTILITY(U,$J,358.3,44565,0)
;;=T43.206A^^164^2208^6
;;^UTILITY(U,$J,358.3,44565,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44565,1,3,0)
;;=3^Underdosing of Antidepressants,Init Encntr
;;^UTILITY(U,$J,358.3,44565,1,4,0)
;;=4^T43.206A
;;^UTILITY(U,$J,358.3,44565,2)
;;=^5050543
;;^UTILITY(U,$J,358.3,44566,0)
;;=T43.206S^^164^2208^7
;;^UTILITY(U,$J,358.3,44566,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44566,1,3,0)
;;=3^Underdosing of Antidepressants,Sequela
;;^UTILITY(U,$J,358.3,44566,1,4,0)
;;=4^T43.206S
;;^UTILITY(U,$J,358.3,44566,2)
;;=^5050545
;;^UTILITY(U,$J,358.3,44567,0)
;;=T43.206D^^164^2208^8
;;^UTILITY(U,$J,358.3,44567,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44567,1,3,0)
;;=3^Underdosing of Antidepressants,Subs Encntr
;;^UTILITY(U,$J,358.3,44567,1,4,0)
;;=4^T43.206D
;;^UTILITY(U,$J,358.3,44567,2)
;;=^5050544
;;^UTILITY(U,$J,358.3,44568,0)
;;=T43.506A^^164^2208^12
;;^UTILITY(U,$J,358.3,44568,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44568,1,3,0)
;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
;;^UTILITY(U,$J,358.3,44568,1,4,0)
;;=4^T43.506A
;;^UTILITY(U,$J,358.3,44568,2)
;;=^5050651
;;^UTILITY(U,$J,358.3,44569,0)
;;=T43.506S^^164^2208^13
;;^UTILITY(U,$J,358.3,44569,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44569,1,3,0)
;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
;;^UTILITY(U,$J,358.3,44569,1,4,0)
;;=4^T43.506S
;;^UTILITY(U,$J,358.3,44569,2)
;;=^5050653
;;^UTILITY(U,$J,358.3,44570,0)
;;=T43.506D^^164^2208^14
;;^UTILITY(U,$J,358.3,44570,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,44570,1,3,0)
;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
;;^UTILITY(U,$J,358.3,44570,1,4,0)
;;=4^T43.506D
;;^UTILITY(U,$J,358.3,44570,2)
;;=^5050652
;;^UTILITY(U,$J,358.3,44571,0)
;;=99201^^165^2209^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2SO 3789 printed Apr 09, 2024@21:12:31 Page 2
IBDEI2SO ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,44559,1,4,0)
+2 ;;=4^T38.3X6A
+3 ;;^UTILITY(U,$J,358.3,44559,2)
+4 ;;=^5049649
+5 ;;^UTILITY(U,$J,358.3,44560,0)
+6 ;;=T38.3X6S^^164^2208^4
+7 ;;^UTILITY(U,$J,358.3,44560,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,44560,1,3,0)
+10 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
+11 ;;^UTILITY(U,$J,358.3,44560,1,4,0)
+12 ;;=4^T38.3X6S
+13 ;;^UTILITY(U,$J,358.3,44560,2)
+14 ;;=^5049651
+15 ;;^UTILITY(U,$J,358.3,44561,0)
+16 ;;=T38.3X6D^^164^2208^5
+17 ;;^UTILITY(U,$J,358.3,44561,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,44561,1,3,0)
+20 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
+21 ;;^UTILITY(U,$J,358.3,44561,1,4,0)
+22 ;;=4^T38.3X6D
+23 ;;^UTILITY(U,$J,358.3,44561,2)
+24 ;;=^5049650
+25 ;;^UTILITY(U,$J,358.3,44562,0)
+26 ;;=T46.5X6A^^164^2208^9
+27 ;;^UTILITY(U,$J,358.3,44562,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,44562,1,3,0)
+30 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
+31 ;;^UTILITY(U,$J,358.3,44562,1,4,0)
+32 ;;=4^T46.5X6A
+33 ;;^UTILITY(U,$J,358.3,44562,2)
+34 ;;=^5051353
+35 ;;^UTILITY(U,$J,358.3,44563,0)
+36 ;;=T46.5X6D^^164^2208^10
+37 ;;^UTILITY(U,$J,358.3,44563,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,44563,1,3,0)
+40 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
+41 ;;^UTILITY(U,$J,358.3,44563,1,4,0)
+42 ;;=4^T46.5X6D
+43 ;;^UTILITY(U,$J,358.3,44563,2)
+44 ;;=^5051354
+45 ;;^UTILITY(U,$J,358.3,44564,0)
+46 ;;=T46.5X6S^^164^2208^11
+47 ;;^UTILITY(U,$J,358.3,44564,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,44564,1,3,0)
+50 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
+51 ;;^UTILITY(U,$J,358.3,44564,1,4,0)
+52 ;;=4^T46.5X6S
+53 ;;^UTILITY(U,$J,358.3,44564,2)
+54 ;;=^5051355
+55 ;;^UTILITY(U,$J,358.3,44565,0)
+56 ;;=T43.206A^^164^2208^6
+57 ;;^UTILITY(U,$J,358.3,44565,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,44565,1,3,0)
+60 ;;=3^Underdosing of Antidepressants,Init Encntr
+61 ;;^UTILITY(U,$J,358.3,44565,1,4,0)
+62 ;;=4^T43.206A
+63 ;;^UTILITY(U,$J,358.3,44565,2)
+64 ;;=^5050543
+65 ;;^UTILITY(U,$J,358.3,44566,0)
+66 ;;=T43.206S^^164^2208^7
+67 ;;^UTILITY(U,$J,358.3,44566,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,44566,1,3,0)
+70 ;;=3^Underdosing of Antidepressants,Sequela
+71 ;;^UTILITY(U,$J,358.3,44566,1,4,0)
+72 ;;=4^T43.206S
+73 ;;^UTILITY(U,$J,358.3,44566,2)
+74 ;;=^5050545
+75 ;;^UTILITY(U,$J,358.3,44567,0)
+76 ;;=T43.206D^^164^2208^8
+77 ;;^UTILITY(U,$J,358.3,44567,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,44567,1,3,0)
+80 ;;=3^Underdosing of Antidepressants,Subs Encntr
+81 ;;^UTILITY(U,$J,358.3,44567,1,4,0)
+82 ;;=4^T43.206D
+83 ;;^UTILITY(U,$J,358.3,44567,2)
+84 ;;=^5050544
+85 ;;^UTILITY(U,$J,358.3,44568,0)
+86 ;;=T43.506A^^164^2208^12
+87 ;;^UTILITY(U,$J,358.3,44568,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,44568,1,3,0)
+90 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
+91 ;;^UTILITY(U,$J,358.3,44568,1,4,0)
+92 ;;=4^T43.506A
+93 ;;^UTILITY(U,$J,358.3,44568,2)
+94 ;;=^5050651
+95 ;;^UTILITY(U,$J,358.3,44569,0)
+96 ;;=T43.506S^^164^2208^13
+97 ;;^UTILITY(U,$J,358.3,44569,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,44569,1,3,0)
+100 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
+101 ;;^UTILITY(U,$J,358.3,44569,1,4,0)
+102 ;;=4^T43.506S
+103 ;;^UTILITY(U,$J,358.3,44569,2)
+104 ;;=^5050653
+105 ;;^UTILITY(U,$J,358.3,44570,0)
+106 ;;=T43.506D^^164^2208^14
+107 ;;^UTILITY(U,$J,358.3,44570,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,44570,1,3,0)
+110 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
+111 ;;^UTILITY(U,$J,358.3,44570,1,4,0)
+112 ;;=4^T43.506D
+113 ;;^UTILITY(U,$J,358.3,44570,2)
+114 ;;=^5050652
+115 ;;^UTILITY(U,$J,358.3,44571,0)
+116 ;;=99201^^165^2209^1
